Department of Psychology, University of Regina, 3737 Wascana Parkway, Regina, SK, Canada.
Curr Psychiatry Rep. 2021 Oct 6;23(11):73. doi: 10.1007/s11920-021-01285-1.
This review considers how reproductive aging may impact the trajectory of menstrually related mood disorders (MRMDs) such as premenstrual dysphoric disorder and considers how the treatment of MRMDs might require adjustment as patients approach midlife.
The early menopause transition is accompanied by important hormonal changes that may exacerbate existing MRMDs. Indeed, recent research confirms that an important subset of women experiences depressive mood in response to perimenopausal elevations in ovarian hormones. In addition, a subset of women with an MRMD may exhibit an increased mood sensitivity to the ovarian hormone withdrawal that accompanies the late menopause transition and early postmenopausal phase. Though additional research is needed to clarify the trajectory of premenstrual dysphoria in the menopause transition, there is reason to believe that health care providers should be vigilant for a potential worsening of symptoms in perimenopause for women with past or current premenstrual dysphoric disorder.
本篇综述探讨了生殖衰老如何影响与月经相关的心境障碍(MRMDs)的病程,如经前烦躁障碍,并考虑了随着患者接近中年,MRMDs 的治疗可能需要调整。
早发性绝经过渡伴随着重要的激素变化,可能使现有的 MRMDs 恶化。事实上,最近的研究证实,相当一部分女性在围绝经期卵巢激素升高时会出现抑郁情绪。此外,一部分 MRMD 患者可能表现出对伴随晚发性绝经过渡和早期绝经后阶段的卵巢激素撤退的情绪敏感性增加。尽管需要进一步研究来阐明绝经过渡期间经前烦躁障碍的病程,但有理由相信,对于过去或现在患有经前烦躁障碍的女性,保健提供者应该警惕围绝经期症状可能恶化。